What You Should Know:
– Arintra, the leading GenAI-native autonomous medical coding platform for healthcare providers, has raised $21 million in Series A funding.
– The round was led by Peak XV with participation from Endeavor Health Ventures, Y Combinator, and other strategic investors.
Arintra Secures $21M Series A to Redefine Revenue Assurance in Healthcare with GenAI-Powered Medical Coding
Transforming Medical Coding into a Strategic Driver for Financial Health
The capital will accelerate nationwide adoption, enhance product development, scale Arintra’s team, and establish a new Bay Area headquarters.
The announcement comes as healthcare organizations face unprecedented financial strain—shrinking margins, a shortage of skilled coders, and increasingly complex payer requirements. Recent policies such as OBBBA are further impacting reimbursement, underscoring the need for solutions that go beyond survival.
While traditional autonomous coding tools focus solely on coding existing charts, Arintra advances the field with Revenue Assurance—a proactive, outcomes-driven approach that maximizes compliant reimbursement, enhances transparency, and streamlines revenue cycle operations.
“Reimbursement in healthcare is designed to keep money away from health systems. While payers evolve rapidly, autonomous coding has lagged,” said Nitesh Shroff, Co-founder and CEO of Arintra. “We saw the opportunity to right-size reimbursement and give healthcare organizations a better way to get properly paid for the care they provide.”
Since launch, Arintra has processed millions of charts and over [$XXX million/$X billion] in healthcare charges, helping clients recover more than [$XX million] in missed revenue while cutting manual work and improving cash flow. Results include:
- Mercyhealth: 5.1% revenue lift, 50% reduction in work queue aging, 32% drop in coding costs
- Reid Health: Shortened accounts receivable cycles and improved coding accuracy across specialties
“Arintra integrates seamlessly with Epic, eliminating billing delays and high denial rates while delivering fully automated charge capture,” said Muhammad Siddiqui, CIO of Reid Health. “It’s one of the few AI tools delivering hard ROI—fast.”
Endeavor Health Ventures, which had direct experience with Arintra in its care settings, also joined the funding round based on its demonstrated impact.
GenAI Meets Deep Clinical Expertise
The idea for Arintra was born from co-founder Preeti Bhargava’s personal encounter with a costly coding error that took months to resolve. This experience revealed the widespread breakdowns in clinical documentation and reimbursement—problems that leave both patients and providers financially vulnerable. Together with Nitesh Shroff, the pair applied their computer science PhDs to reimagine medical coding as a lever for healthcare’s financial sustainability.
Arintra unites autonomous medical coding, clinical documentation improvement, and denial prevention into a single platform. By ensuring providers document accurately, code precisely, and justify charges effectively, the platform secures full, compliant reimbursement with fewer delays and less manual intervention.
Built on large language models and clinical knowledge graphs, Arintra interprets patient charts in context, applying specialty-specific coding guidelines with precision. Every code is explainable and auditable, fostering trust in a high-stakes domain. The platform integrates natively with leading EHRs such as Epic and Athena, operating seamlessly within existing workflows.
With measurable ROI, proven customer outcomes, and a deep understanding of healthcare’s revenue challenges, Arintra is positioned to become the trusted partner for Revenue Assurance—helping providers achieve sustainable financial health in an era of increasing complexity.
